Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides

Koushik Chandra; Michal Maes; Assaf Friedler

doi:10.4155/fmc.15.46

Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides

Koushik Chandra
, Michal Maes
, Assaf Friedler^*

^*Corresponding author for this work

Institute of Chemistry

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Protein-protein interactions (PPI) are essential in every step of the HIV replication cycle. Mapping the interactions between viral and host proteins is a fundamental target for the design and development of new therapeutics. In this review, we focus on rational development of anti-HIV-1 peptides based on mapping viral-host and viral-viral protein interactions all across the HIV-1 replication cycle. We also discuss the mechanism of action, specificity and stability of these peptides, which are designed to inhibit PPI. Some of these peptides are excellent tools to study the mechanisms of PPI in HIV-1 replication cycle and for the development of anti-HIV-1 drug leads that modulate PPI.

Original language	English
Pages (from-to)	1055-1077
Number of pages	23
Journal	Future Medicinal Chemistry
Volume	7
Issue number	8
DOIs	https://doi.org/10.4155/fmc.15.46
State	Published - 1 Jun 2015

Bibliographical note

Publisher Copyright:
© 2015 Future Science Ltd.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.4155/fmc.15.46

Cite this

@article{6257fd60633942ab9298cf37e3b892d1,

title = "Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides",

abstract = "Protein-protein interactions (PPI) are essential in every step of the HIV replication cycle. Mapping the interactions between viral and host proteins is a fundamental target for the design and development of new therapeutics. In this review, we focus on rational development of anti-HIV-1 peptides based on mapping viral-host and viral-viral protein interactions all across the HIV-1 replication cycle. We also discuss the mechanism of action, specificity and stability of these peptides, which are designed to inhibit PPI. Some of these peptides are excellent tools to study the mechanisms of PPI in HIV-1 replication cycle and for the development of anti-HIV-1 drug leads that modulate PPI.",

author = "Koushik Chandra and Michal Maes and Assaf Friedler",

note = "Publisher Copyright: {\textcopyright} 2015 Future Science Ltd.",

year = "2015",

month = jun,

day = "1",

doi = "10.4155/fmc.15.46",

language = "אנגלית",

volume = "7",

pages = "1055--1077",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Taylor and Francis Ltd.",

number = "8",

}

TY - JOUR

T1 - Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides

AU - Chandra, Koushik

AU - Maes, Michal

AU - Friedler, Assaf

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Protein-protein interactions (PPI) are essential in every step of the HIV replication cycle. Mapping the interactions between viral and host proteins is a fundamental target for the design and development of new therapeutics. In this review, we focus on rational development of anti-HIV-1 peptides based on mapping viral-host and viral-viral protein interactions all across the HIV-1 replication cycle. We also discuss the mechanism of action, specificity and stability of these peptides, which are designed to inhibit PPI. Some of these peptides are excellent tools to study the mechanisms of PPI in HIV-1 replication cycle and for the development of anti-HIV-1 drug leads that modulate PPI.

AB - Protein-protein interactions (PPI) are essential in every step of the HIV replication cycle. Mapping the interactions between viral and host proteins is a fundamental target for the design and development of new therapeutics. In this review, we focus on rational development of anti-HIV-1 peptides based on mapping viral-host and viral-viral protein interactions all across the HIV-1 replication cycle. We also discuss the mechanism of action, specificity and stability of these peptides, which are designed to inhibit PPI. Some of these peptides are excellent tools to study the mechanisms of PPI in HIV-1 replication cycle and for the development of anti-HIV-1 drug leads that modulate PPI.

UR - https://www.scopus.com/pages/publications/84931044220

U2 - 10.4155/fmc.15.46

DO - 10.4155/fmc.15.46

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 26062401

AN - SCOPUS:84931044220

SN - 1756-8919

VL - 7

SP - 1055

EP - 1077

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

IS - 8

ER -

Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this